| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Histopathology, Royal Postgraduate Medical School, Hammersmith Hospital, London W12, and Histopathology Unit, Imperial Cancer Research Fund, London WC2A, United Kingdom
In an attempt to demonstrate the relationship between aberrant crypt foci (ACF) and subsequent colonic neoplasms, we investigated the distribution of ACF in the dimethylhydrazine (DMH) model of colonic carcinogenesis in the rat. DMH was given to male Wistar rats by s.c. injection in a dosage of 15 mg/kg body weight once a week for 19 weeks. As a result, eight poorly differentiated, mucin-secreting carcinomas, two well-differentiated tubular adenocarcinomas, and four adenomas developed in 35 rats autopsied at 24 weeks after the first injection of DMH. The location of each type of tumor was site specific. Poorly differentiated, mucin-secreting carcinomas of signet-ring type occurred only in the proximal colon; the mean location of these lesions was 17.6 ± 3.8% (SE; range, 039%) of the length of the colon. Well-differentiated tubular adenocarcinomas and adenomas developed in the distal colon; the mean location of these lesions was 76.7% ± 4.9 (SE; range, 6090%) of the length of the colon. These was a mean number of 276 ± 29 (SE) ACF per colon; these were present at between 40 and 90% of the colonic length, peaking at 70%. We conclude that ACF are marker lesions for colonic neoplasms, but only in the distal colon where tumors follow the adenoma-carcinoma sequence; this is not so for the proximal colon, where poorly differentiated, mucin-secreting carcinomas are found. These findings suggest that these latter tumors well may arise de novo and indicate that studies that attempt to correlate ACF with subsequent tumor formation must take cognizance, not only of the site, but also of the tumor type.
1 This work was supported by grants from the British Council and the Imperial Cancer Research Fund (to H-S. P.).
2 To whom requests for reprints should be addressed, at Histopathology Unit, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom. Phone: 44-(0)171-269-3425; Fax: 44-(0)171-269-3491; E-mail: park.icrf.icnet.uk.
Received 5/16/97. Accepted 8/15/97.
This article has been cited by other articles:
![]() |
L Ziliotto, L. Barbisan, and M. Rodrigues Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci Human and Experimental Toxicology, June 1, 2008; 27(6): 505 - 511. [Abstract] [PDF] |
||||
![]() |
D. W.L. Ma, R. H. Finnell, L. A. Davidson, E. S. Callaway, O. Spiegelstein, J. A. Piedrahita, J. M. Salbaum, C. Kappen, B. R. Weeks, J. James, et al. Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis Cancer Res., February 1, 2005; 65(3): 887 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Nambiar, M. Nakanishi, R. Gupta, E. Cheung, A. Firouzi, X.-J. Ma, C. Flynn, M. Dong, K. Guda, J. Levine, et al. Genetic signatures of High- and Low-Risk Aberrant Crypt Foci in a Mouse Model of Sporadic Colon Cancer Cancer Res., September 15, 2004; 64(18): 6394 - 6401. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Jackson, P. J. O'Connor, D. P. Cooper, G. P. Margison, and A. C. Povey Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine Carcinogenesis, March 1, 2003; 24(3): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Povey, A. F. Badawi, D. P. Cooper, C. N. Hall, K. L. Harrison, P. E. Jackson, N. P. Lees, P. J. O'Connor, and G. P. Margison DNA Alkylation and Repair in the Large Bowel: Animal and Human Studies J. Nutr., November 1, 2002; 132(11): 3518S - 3521. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Salim, H. Wanibuchi, K. Morimura, T. Murai, S. Makino, T. Nomura, and S. Fukushima Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)--modulation by long-chain fatty acids Carcinogenesis, September 1, 2002; 23(9): 1519 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Kishimoto, N Takata, T Jinnai, T Morisawa, G Shiota, H Kawasaki, and J Hasegawa Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane Gut, December 1, 2000; 47(6): 812 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Gee, H.P.J.M. Noteborn, A.C.J. Polley, and I.T. Johnson Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein Carcinogenesis, December 1, 2000; 21(12): 2255 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Papanikolaou, Q.-S. Wang, D. Papanikolaou, H. E. Whiteley, and D. W. Rosenberg Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis Carcinogenesis, August 1, 2000; 21(8): 1567 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Soler, R.D. Miller, K. V. Laughlin, N. Z. Carp, D. M. Klurfeld, and J. M. Mullin Increased tight junctional permeability is associated with the development of colon cancer Carcinogenesis, August 1, 1999; 20(8): 1425 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Latham, E. K. Lund, and I. T. Johnson Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon Carcinogenesis, April 1, 1999; 20(4): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |